guidelines:
  1: Intracranial_hemorrhage_risk_from_thrombolytic_therapy.v1
test_cases:
- id: Risk 0.69%
  input:
    1:
      gt0003|Age: 1|local::at0005|75 or older|
      gt0004|Gender: 0|local::at0008|Male|
      gt0005|Race: 0|local::at0011|Other|
      gt0006|Prior history of stroke: 0|local::at0014|No|
      gt0007|Systolic blood pressure: 0|local::at0017|<160 mmHg|
      gt0008|Body weight: 0|local::at0020|>65 kg (female), >80 kg (male)|
      gt0009|INR >4 OR prothrombin time >24 seconds: 0|local::at0023|No|
      gt0010|TPA as thrombolytic therapy: 0|local::at0026|No|
  expected_output:
    1:
      gt0012|Intracranial hemorrhage risk score: 1
      gt0014|Intracranial hemorrhage risk: local::at0003|0.69%|

- id: Risk 1.02%
  input:
    1:
      gt0003|Age: 0|local::at0006|Below 75|
      gt0004|Gender: 1|local::at0009|Female|
      gt0005|Race: 1|local::at0012|Black|
      gt0006|Prior history of stroke: 0|local::at0014|No|
      gt0007|Systolic blood pressure: 0|local::at0017|<160 mmHg|
      gt0008|Body weight: 0|local::at0020|>65 kg (female), >80 kg (male)|
      gt0009|INR >4 OR prothrombin time >24 seconds: 0|local::at0014|No|
      gt0010|TPA as thrombolytic therapy: 0|local::at0014|No|
  expected_output:
    1:
      gt0012|Intracranial hemorrhage risk score: 2
      gt0014|Intracranial hemorrhage risk: local::at0004|1.02%|

- id: Risk 1.63%
  input:
    1:
      gt0003|Age: 0|local::at0006|Below 75|
      gt0004|Gender: 1|local::at0009|Female|
      gt0005|Race: 1|local::at0012|Black|
      gt0006|Prior history of stroke: 0|local::at0014|No|
      gt0007|Systolic blood pressure: 1|local::at0018|≥160 mmHg|
      gt0008|Body weight: 0|local::at0020|>65 kg (female), >80 kg (male)|
      gt0009|INR >4 OR prothrombin time >24 seconds: 0|local::at0014|No|
      gt0010|TPA as thrombolytic therapy: 0|local::at0014|No|
  expected_output:
    1:
      gt0012|Intracranial hemorrhage risk score: 3
      gt0014|Intracranial hemorrhage risk: local::at0005|1.63%|

- id: Risk 2.49%
  input:
    1:
      gt0003|Age: 0|local::at0006|Below 75|
      gt0004|Gender: 1|local::at0009|Female|
      gt0005|Race: 1|local::at0012|Black|
      gt0006|Prior history of stroke: 1|local::at0015|Yes|
      gt0007|Systolic blood pressure: 1|local::at0018|≥160 mmHg|
      gt0008|Body weight: 0|local::at0020|>65 kg (female), >80 kg (male)|
      gt0009|INR >4 OR prothrombin time >24 seconds: 0|local::at0014|No|
      gt0010|TPA as thrombolytic therapy: 0|local::at0014|No|
  expected_output:
    1:
      gt0012|Intracranial hemorrhage risk score: 4
      gt0014|Intracranial hemorrhage risk: local::at0006|2.49%|

- id: Risk 4.11%
  input:
    1:
      gt0003|Age: 0|local::at0006|Below 75|
      gt0004|Gender: 1|local::at0009|Female|
      gt0005|Race: 1|local::at0012|Black|
      gt0006|Prior history of stroke: 1|local::at0015|Yes|
      gt0007|Systolic blood pressure: 1|local::at0018|≥160 mmHg|
      gt0008|Body weight: 0|local::at0020|>65 kg (female), >80 kg (male)|
      gt0009|INR >4 OR prothrombin time >24 seconds: 1|local::at0015|Yes|
      gt0010|TPA as thrombolytic therapy: 0|local::at0014|No|
  expected_output:
    1:
      gt0012|Intracranial hemorrhage risk score: 5
      gt0014|Intracranial hemorrhage risk: local::at0007|4.11%|